<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02016456</url>
  </required_header>
  <id_info>
    <org_study_id>AMH/021213</org_study_id>
    <nct_id>NCT02016456</nct_id>
  </id_info>
  <brief_title>TMS Treatment for Depression in the National Health Service</brief_title>
  <acronym>TDEP</acronym>
  <official_title>An Evaluation of Transcranial Magnetic Stimulation in the National Health Service</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Mental Health Nottingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nottinghamshire Healthcare NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institute of Mental Health Nottingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research programme purports to test the effectiveness of two Transcranial Magnetic
      Stimulation (TMS) protocols (Repetitive high frequency protocol and Theta Burst protocol) in
      reducing the symptoms of depression. The study also uses Magnetic Resonance Imaging (MRI)
      scans to improve the localization of TMS targets.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of responders defined as subjects with 50% reduction in the 17-item Hamilton Depression Scale Score</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean change in Beck Depression Inventory scores</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in processing speed (using modified digit-symbol test) scores</measure>
    <time_frame>4 weeks and 3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in Clinical Global Impression scores</measure>
    <time_frame>4 weeks and 3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in Social and Occupational Functioning Assessment scores</measure>
    <time_frame>4 weeks and 3 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Theta-Burst Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Theta-Burst protocol for transcranial magnetic stimulation on dorsolateral prefrontal cortex (exact location to be determined using neuronavigation guided by Magnetic Resonance Imaging)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Frequency stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High frequency Transcranial Magnetic Stimulation using the standard protocol for depression, on left dorsolateral prefrontal cortex.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Theta-Burst Stimulation</intervention_name>
    <description>At 80% motor threshold determined using single pulse stimuli. Depending on the hemisphere determined by connectivity analysis and neuronavigation in each individual, either continuous (left prefrontal) or intermittent (right prefrontal) train of pulses will be delivered.</description>
    <arm_group_label>Theta-Burst Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High frequency stimulation</intervention_name>
    <description>Left prefrontal stimulation. 120% motor threshold with a pulse sequence of 10 Hz for 4 seconds, followed by a 26 second quiet period. Treatment will last for a total of 37.5 minutes this is a total of 3,000 pulses</description>
    <arm_group_label>High Frequency stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of depressive disorder (DSM-IV)

          -  Diagnosis of treatment resistance (at least stage 1 as defined by Thase &amp; Rush, 1997
             for depression)

          -  Female or male between 18 and 70 years

        Exclusion Criteria:

          -  History of Bipolar disorder

          -  Clinically relevant neurological comorbidity such as brain neoplasm, cerebral vascular
             events, epilepsy, neurodegenerative disorders, prior brain surgery

          -  Metal objects in and around body that cannot be removed

          -  Pregnancy

          -  Cardiac pacemaker or implanted medication pump

          -  Major unstable medical illness

          -  Change in prescribed medication in the 2 weeks preceding the start of TMS trial

          -  Current alcohol/stimulant dependence with propensity for toxic/withdrawal seizures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sudheer Lankappa, MRCPsych</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nottinghamshire Healthcare NHS Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Neuromodulation Unit, Nottinghamshire Healthcare NHS Trust</name>
      <address>
        <city>Nottingham</city>
        <state>England</state>
        <zip>NG2 7UH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.nlm.nih.gov/medlineplus/depression.html</url>
  </link>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2013</study_first_submitted>
  <study_first_submitted_qc>December 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 20, 2013</study_first_posted>
  <last_update_submitted>August 31, 2017</last_update_submitted>
  <last_update_submitted_qc>August 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institute of Mental Health Nottingham</investigator_affiliation>
    <investigator_full_name>Sudheer Lankappa</investigator_full_name>
    <investigator_title>Consultant Psychiatrist</investigator_title>
  </responsible_party>
  <keyword>Transcranial Magnetic Stimulation</keyword>
  <keyword>Neuronavigation</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

